A retrospective, observational nationwide study of incidence of seizures in recipients who took SARS-CoV-2 vaccines in Mexico
Latest Information Update: 18 Aug 2022
At a glance
- Drugs Ad5-nCoV Tianjin CanSino Biotechnology (Primary) ; Elasomeran (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions
Most Recent Events
- 18 Aug 2022 New trial record
- 09 Aug 2022 Results published in the Epilepsia